Get startedLog in
    Picture of Bellicum Pharmaceuticals logo

    BLCM — Bellicum Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Bellicum Pharmaceuticals Q2 Net Loss Per Share Attributable $0.60

    Picture of Bellicum Pharmaceuticals logoBellicum Pharmaceuticals
    07/08/2018 22:47
    Aug 7 (Reuters) - Bellicum Pharmaceuticals Inc  BLCM.O :
    * BELLICUM PHARMACEUTICALS REPORTS SECOND QUARTER 2018
FINANCIAL
RESULTS
    * QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON
SHAREHOLDERS
$0.60
    * Q2 EARNINGS PER SHARE VIEW $-0.55 -- THOMSON REUTERS
I/B/E/S

Source text for Eikon:  ID:nGNX897xpX 
Further company coverage:  BLCM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Bellicum Pharmaceuticals

    See all news